Pathology of MRI and second-look ultrasound detected multifocal breast cancer

References

• Warner E, Messersmith H, Causer P, et al. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med. 2008;148(9):671–679. doi: 10.7326/0003-4819-148-9-200805060-00007.
   PubMed Web of Science ®Google Scholar
• Carin AJ, Moliere S, Gabriele V, et al. Relevance of breast MRI in determining the size and focality of invasive breast cancer treated by mastectomy: a prospective study. World J Surg Oncol. 2017;15(1):128. doi: 10.1186/s12957-017-1197-1.
   PubMedGoogle Scholar
• Perlet C, Heywang-Kobrunner SH, Heinig A, et al. Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions. Cancer. 2006;106(5):982–990. doi: 10.1002/cncr.21720.
   PubMed Web of Science ®Google Scholar
• Spick C, Baltzer PA. Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis. Radiology. 2014;273(2):401–409. doi: 10.1148/radiol.14140474.
   PubMed Web of Science ®Google Scholar
• Hong MJ, Cha JH, Kim HH, et al. Second-look ultrasonography for MRI-detected suspicious breast lesions in patients with breast cancer. Ultrasonography. 2015;34(2):125–132. doi: 10.14366/usg.14046.
   PubMedGoogle Scholar
• Mazzei MA, Di Giacomo L, Fausto A, et al. Efficacy of second-look ultrasound with MR coregistration for evaluating additional enhancing lesions of the breast: review of the literature. Biomed Res Int. 2018;2018:3896946–3896948. doi: 10.1155/2018/3896946.
   PubMed Web of Science ®Google Scholar
• Park VY, Kim MJ, Kim EK, et al. Second-look US: how to find breast lesions with a suspicious MR imaging appearance. Radiographics. 2013;33(5):1361–1375. doi: 10.1148/rg.335125109.
   PubMed Web of Science ®Google Scholar
• Australian Government Department of Health. Medicare Benefits Schedule - Item 63489. 2022; Available from: http://www9.health.gov.au/mbs/fullDisplay.cfm?type=item&q=63489&qt=item.
   Google Scholar
• Meissnitzer M, Dershaw DD, Lee CH, et al. Targeted ultrasound of the breast in women with abnormal MRI findings for whom biopsy has been recommended. AJR Am J Roentgenol. 2009;193(4):1025–1029. doi: 10.2214/AJR.09.2480.
   PubMed Web of Science ®Google Scholar
• Sim LS, Hendriks JH, Bult P, et al. US correlation for MRI-detected breast lesions in women with familial risk of breast cancer. Clin Radiol. 2005;60(7):801–806. doi: 10.1016/j.crad.2004.12.005.
   PubMed Web of Science ®Google Scholar
• Abe H, Schmidt RA, Shah RN, et al. MR-directed (“Second-Look”) ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR Am J Roentgenol. 2010;194(2):370–377. doi: 10.2214/AJR.09.2707.
   PubMed Web of Science ®Google Scholar
• Candelaria R, Fornage BD. Second-look US examination of MR-detected breast lesions. J Clin Ultrasound. 2011;39(3):115–121. doi: 10.1002/jcu.20784.
   PubMed Web of Science ®Google Scholar
• Demartini WB, Eby PR, Peacock S, et al. Utility of targeted sonography for breast lesions that were suspicious on MRI. AJR Am J Roentgenol. 2009;192(4):1128–1134. doi: 10.2214/AJR.07.3987.
   PubMed Web of Science ®Google Scholar
• Chikarmane SA, Jin B, Giess CS. Accuracy of MRI-directed ultrasound and subsequent ultrasound-guided biopsy for suspicious breast MRI findings. Clin Radiol. 2020;75(3):185–193. doi: 10.1016/j.crad.2019.10.013.
   PubMed Web of Science ®Google Scholar
• Lee AY, Nguyen VT, Arasu VA, et al. Sonographic-MRI correlation after percutaneous sampling of targeted breast ultrasound lesions: initial experiences with Limited-Sequence unenhanced MRI for postprocedural clip localization. AJR Am J Roentgenol. 2018;210(4):927–934. doi: 10.2214/AJR.17.18489.
   PubMed Web of Science ®Google Scholar
• McDonald ES, Clark AS, Tchou J, et al. Clinical diagnosis and management of breast cancer. J Nucl Med. 2016;57 Suppl 1(Supplement 1):9S–16S. p. doi: 10.2967/jnumed.115.157834.
   PubMedGoogle Scholar
• Tot T, Tabár L. The role of radiological–pathological correlation in diagnosing early breast cancer: the pathologist’s perspective. Virchows Arch. 2011;458(2):125–131. doi: 10.1007/s00428-010-1005-6.
   PubMed Web of Science ®Google Scholar
• Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26(19):3248–3258. doi: 10.1200/JCO.2007.15.2108.
   PubMed Web of Science ®Google Scholar
• Park SY, Han BK, Ko ES, et al. Additional lesions seen in magnetic resonance imaging of breast cancer patients: the role of second-look ultrasound and imaging-guided interventions. Ultrasonography. 2019;38(1):76–82. doi: 10.14366/usg.18002.
   PubMed Web of Science ®Google Scholar
• Steinhof-Radwańska K, Lorek A, Holecki M, et al. Multifocality and multicentrality in breast cancer: comparison of the efficiency of mammography, contrast-enhanced spectral mammography, and magnetic resonance imaging in a group of patients with primarily operable breast cancer. Curr Oncol. 2021;28(5):4016–4030. doi: 10.3390/curroncol28050341.
   PubMed Web of Science ®Google Scholar
• Neri A, Marrelli D, Megha T, et al. Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases. BMC Surg. 2015;15(1):1. doi: 10.1186/1471-2482-15-1.
   PubMedGoogle Scholar
• Pekar G, Hofmeyer S, Tabar L, et al. Multifocal breast cancer documented in large-format histology sections: long-term follow-up results by molecular phenotypes. Cancer. 2013;119(6):1132–1139. doi: 10.1002/cncr.27877.
   PubMed Web of Science ®Google Scholar
• LaTrenta LR, Menell JH, Morris EA, et al. Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology. 2003;227(3):856–861. doi: 10.1148/radiol.2273012210.
   PubMed Web of Science ®Google Scholar
• Jabbar SB, Lynch B, Seiler S, et al. Pathologic findings of breast lesions detected on magnetic resonance imaging. Arch Pathol Lab Med. 2017;141(11):1513–1522. doi: 10.5858/arpa.2016-0552-OA.
   PubMed Web of Science ®Google Scholar
• Rudat V, Nour A, Almuraikhi N, et al. MRI and ultrasonography for assessing multifocal disease and tumor size in breast cancer: comparison with histopathological results. Gulf J Oncol. 2015;1(17):65–72.
   PubMedGoogle Scholar
• Choi Y, Kim EJ, Seol H, et al. The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast. Hum Pathol. 2012;43(1):48–55. doi: 10.1016/j.humpath.2010.08.026.
   PubMed Web of Science ®Google Scholar
• Lochhead P, Chan AT, Nishihara R, et al. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression. Mod Pathol. 2015;28(1):14–29. doi: 10.1038/modpathol.2014.81.
   PubMed Web of Science ®Google Scholar
• Gruber IV, Rueckert M, Kagan KO, et al. Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer. BMC Cancer. 2013;13(1):328. doi: 10.1186/1471-2407-13-328.
   PubMedGoogle Scholar
• Taydaş O, Durhan G, Akpınar MG, et al. Comparison of MRI and US in tumor size evaluation of breast cancer patients receiving neoadjuvant chemotherapy. Eur J Breast Health. 2019;15(2):119–124. doi: 10.5152/ejbh.2019.4547.
   PubMed Web of Science ®Google Scholar